The new report by Expert Market Research titled, ‘Global Cell Counting Market Share, Size, Growth, Analysis, Report and Forecast 2021-2026’, gives an in-depth analysis of the global cell counting market, assessing the market based on its segments like product type, end use, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2016-2026)
- Historical Market Size (2020): USD 10 Billion
- Forecast CAGR (2021-2026): 10%
- Forecast Market Size (2026): USD 15.2 Billion
During the projection period, hospitals and diagnostic laboratories are estimated to observe significant growth. This can be attributed to an increase in capital expenditure for the development of cell culture-based vaccines and the rapid expansion of the pharmaceutical industry. The rising prevalence of various chronic ailments, such as cancer, HIV-AIDS, leukaemia, Alzheimer’s, etc., is propelling the demand for cell counting techniques. The growing adoption of cell counting instruments across diverse medical fields, such as molecular biology, immunology, pathology, etc., for developing next-generation therapeutics is also augmenting the market growth. In addition to this, the increasing utilisation of cell counting for the identification and determination of primary tumours, circulating tumours, and metastatic tumour is further bolstering the market growth. The widespread adoption of stem cell therapy is also propelling the demand for various cell counting instruments on a global level.
Cell Counting Industry Definition and Major Segments
Cell counting refers to a technique used to analyse the cells or micelles that are usually suspended in blood or other body fluids. Some of the standard instruments used for cell counting includes hemocytometers, spectrophotometers, flow cytometers, and automated cell counters, among others. Cell counting aids in classifying cell types and detecting disease through probes to develop the best treatment plan for the patient. It also helps in understanding the structure and composition of the cells for chromosome analysis, protein expression, cancer diagnosis, and haematological malignancies, among others.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/cell-counting-market/requestsample
By product type, the industry is segmented into:
- Instruments
- Spectrophotometers
- Flow Cytometers
- Haematology Analysers
- Cell Counters
- Others
- Consumables and Accessories
- Media, Sera, and Reagents
- Assay Kits
- Others
The market can be broadly categorised on the basis of end use into:
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Others
On the basis of region, the industry is divided into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Cell Counting Market Trends
The rising awareness of numerous benefits of cell counting techniques in immunophenotyping, cell sorting, cell proliferation assays, and intracellular calcium flux is further driving the market growth. The increasing investments by several government bodies in extensive research and development activities pertaining to the fields of biotechnology, oncology stem cell therapeutics, etc., are also bolstering the adoption of cell counting techniques. The presence of an array of medical research and biopharmaceutical businesses is anticipated to drive market growth in the coming years. With the rapid technological advancements, the market is predicted to be driven by innovations in existing products as well as the launch of new data visualisation and analysis tools. The market growth can also be associated with the increase in the number of proteomics and genomics researchers.
Key Market Players
The major players in the market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., and PerkinElmer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Read More Reports:
Breast Cancer Therapeutics Market
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact:
Company Name: Claight Corporation
Contact Person: James Rowan, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com